NVG-291 Dosing Completes & Balancing Self-pity and Grace

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how a trial testing NVG-291 has completed dosing in a final group of healthy postmenopausal women. He also reads “Striking a Balance Between Self-pity and Giving Yourself Grace” by Benjamin Hofmeister, from his column “Chairborne.”=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/=====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/